Oncology & Cancer

Scientists explore potential new treatments for glioblastoma

A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.

Oncology & Cancer

Tool predicts nerve damage from breast cancer treatment

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at Linköping University have developed a tool that can predict the risk level ...

page 2 from 40